The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global chondroitin sulfate market grew at a CAGR of around 4% during 2015-2020. Chondroitin sulfate (CS) is a water-soluble polymer comprising alternating N-Acetylgalactosamine and glucuronic acid, which is naturally found in the cartilage, bone and cornea of animals. CS (C6H13NO5) is anti-atherogenic, inflammatory, thrombogenic and assists in the performance of coagulant activities. Consequently, it is utilized in oral delivery of insulin, proteins and peptides and as a skin substitute and biomaterial for wound healing in the healthcare sector.
CS acts as a precursor for inhibiting degradation, stimulating synthesis and improving the healing of articular cartilage. This represents one of the primary factors escalating the demand for CS-based injectable hydrogels in cartilage tissue engineering for fabricating purposes. Moreover, as it is an enzymatically biodegradable polysaccharide and has high water solubility and lack of mechanical stability, CS is modified with materials like collagen to be utilized in scaffold matrices and other drug delivery applications. Furthermore, it is being used in dietary supplements for relieving pain and disability of individuals with musculoskeletal pathologies or osteoarthritis. In line with this, CS serves as a template for generating hydroxyapatite nanocrystals, thereby contributing to the market growth. It is also gaining traction as an antistatic agent in the cosmetics industry for manufacturing hair conditioning products. However, the surging cases of the coronavirus disease (COVID-19), the imposition of lockdown restrictions in various countries and subsequent halt in the manufacturing units are anticipated to hinder the market growth. The market will experience growth on account of the growing access to healthcare services and the introduction of innovative CS products. Looking forward, IMARC Group expects the global chondroitin sulfate market to continue its moderate growth during the next five years.
IMARC Group provides an analysis of the key trends in each sub-segment of the global chondroitin sulfate market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, source, form and application.
Breakup by Source:
Breakup by Form:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Bioiberica S.A.U., BRF S.A., HeBei SanXin Industrial Group, Maypro Industries Inc., Merck KGaA, Pacific Rainbow International Inc., Qingdao Wantuming Biological Products Co. Ltd., Seikagaku Corporation, Sino Siam Biotechnique Company Limited, Sioux Pharm Inc., Synutra International Inc. and ZPD A/S.
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at